Kirchheim, Germany

Ernst Langguth

This inventor holds 6 USPTO granted patents. Top assignee: Basf Aktiengesellschaft. Active years: 1996-2001.


% Patents Active = 83.3

Average Co-Inventor Count = 4.4

ph-index = 3

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 1996-2001

Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovations of Ernst Langguth

Introduction

Ernst Langguth is a notable inventor based in Kirchheim, Germany. He has made significant contributions to the field of chemistry, particularly in the development of catalysts and processes for organic compounds. With a total of 6 patents to his name, Langguth's work has had a meaningful impact on various industrial applications.

Latest Patents

One of Langguth's latest patents is focused on a catalyst and process for preparing 2-buten-1-ol compounds. This innovation showcases his expertise in chemical processes and his commitment to advancing the field. The patent reflects his ability to address complex challenges in chemical synthesis.

Career Highlights

Langguth is currently employed at BASF Aktiengesellschaft, a leading global chemical company. His role at BASF has allowed him to collaborate with other talented professionals and contribute to groundbreaking research and development projects. His work has not only advanced his career but has also contributed to the company's reputation for innovation.

Collaborations

Throughout his career, Langguth has worked alongside esteemed colleagues such as Franz Josef Bröcker and Werner Aquila. These collaborations have fostered a creative environment that encourages the exchange of ideas and the pursuit of innovative solutions.

Conclusion

Ernst Langguth's contributions to the field of chemistry through his patents and collaborations highlight his role as a significant inventor. His work continues to influence the industry and inspire future innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…